CClinicalTrials.gg
Sign In
TerminatedNCT04241757EGGUpdated Jun 22, 2023

Electrocardiogram in General Practice : the EGG Study

An observational study in Indication for ElectroCardioGram, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Terminated at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-22.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Observational

Why this study was terminated
The EGG study is no longer in progress, as the association that carried it out (IRMG) has had to close due to the impact of the Covid crisis on continuing education.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
888
Ages
18 Years and older
Sex
All
01

Study summary

Existing resources to assist interpretation of ElectroCardioGram (ECG) in general practice provide specialized and comprehensive reading based on pathologies and ElectroCardioGram (ECG) signs rather than ElectroCardioGram (ECG) indications.

Describing practices in general medicine could help prioritize the relevance of clinical and ECG signs for the general practitioner, enabling to adjust the reading given the context.

Read the detailed description

The primary objective of this study is to describe the clinical signs and ElectroCardioGram (ECG) in situations indicating an ElectroCardioGram (ECG) in general practice.

02

Conditions studied

  • Indication for ElectroCardioGram

Keywords

  • ElectroCardioGram
  • General practice
  • Diagnosis
  • Signs and symptoms
  • Feasibility studies
03

In context

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne is the lead sponsor of 578 studies on the registry; 128 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patient with indication of ElectroCardioGram (ECG) will be included.

Inclusion criteria

  • Patient consulting one of the generalist practitioner investigators
  • In doctor's office or at home, scheduled or not,
  • During normal surgery hours or out-of-hours service,
  • Whatever the reason for consultation,
  • Aged 18 years or older,
  • Having an indication of ElectroCardioGram (ECG) and/or request certificate of non-contra-indication to the practice of physical activity certificate of non-contra-indication to the practice of physical activity

Exclusion criteria

Exclusion Criteria:

  • ElectroCardioGram (ECG) not performed due to emergency context
  • Patient with cognitive impairment who cannot give consent to participate in the study and / or patient under guardianship
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
888 participants (actual)
Patient registry
No

Groups and cohorts

  • Patient with indication of ElectroCardioGram (ECG)

    Patient with indication of ElectroCardioGram (ECG) will be included. They will have a collection of results ElectroCardioGram (ECG).

    Diagnostic Test: ElectroCardioGram (ECG)

Interventions

  • Diagnostic testElectroCardioGram (ECG)

    Collection of results ElectroCardioGram (ECG).

06

What researchers measure

Primary outcomes

  1. Description of clinical signs

    Prevalence of each clinical sign within each Electrocardiogram indication

    Time frame: day 0

  2. Description of clinical signs ElectroCardioGram (ECG) sign

    Prevalence of each sign on the Electrocardiogram within each indication.

    Time frame: day 0

Secondary outcomes

  1. Difficulties in carrying out the Electrocardiogram

    Duration of the Electrocardiogram (minutes) Measured by average duration of the ECG, prevalence of the difficulties of realization and interpretation mentioned by the investigators.

    Time frame: Day 0

  2. Initial management types

    Prevalence of initial management types (certificate, medication, addressing) at 1 month.

    Time frame: Months 1

  3. Diagnosis types

    Prevalence of diagnosis types at 1 month.

    Time frame: Months 1

07

Study locations

1 site
  • Association CNGE IRMG
    Saint-Étienne, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04241757
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
Association CNGE IRMG
Responsible party
Sponsor
First posted
Jan 27, 2020
Start date
Sep 17, 2019
Primary completion
Oct 1, 2021
Completion
Nov 19, 2021
Last update
Jun 22, 2023

Study contacts

Paul FRAPPE, MD
principal investigator · CHU DE SAINT-ETIENNE

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Centre Hospitalier Universitaire de Saint Etienne

Start the discussion